Medicine & Life Sciences
Prostate-Specific Antigen
100%
N,N-diethyl-2-(2-(4-methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
62%
Prostatic Neoplasms
58%
Membranes
58%
Positron-Emission Tomography
43%
Molecular Imaging
41%
Glutamate Carboxypeptidase II
35%
fialuridine
31%
Neoplasms
29%
Macrophages
25%
Single-Photon Emission-Computed Tomography
23%
Heterografts
23%
Thymidine Kinase
21%
Brain
20%
Tuberculosis
19%
Radiopharmaceuticals
18%
Bacterial Infections
16%
Inflammation
16%
Neuroimaging
16%
Optical Imaging
16%
Urea
15%
Single Photon Emission Computed Tomography Computed Tomography
15%
Blood-Brain Barrier
15%
Lung
13%
Acids
13%
Animals
13%
Ligands
13%
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
13%
N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine
12%
4-cyano-N-(2-(1-cyclohexen-1-yl)-4-(1-((dimethylamino)acetyl)-4-piperidinyl)phenyl)-1H-imidazole-2-carboxamide
12%
5'-(2-fluorophenyl)-spiro(1-azabicyclo(2.2.2)octane-3,2'(3'H)-furo(2,3-b)pyridine)
11%
5-iodouracil
11%
Autoradiography
11%
Radiometry
11%
2-(3-(1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedioic acid
11%
Collagen
11%
(125)I-5-trimethylstannyl-1-(2-deoxy-2-fluoro-beta-D-arabino-furanosyl)uracil
10%
human FOLH1 protein
10%
Nanoparticles
10%
GW 7845
10%
Glutamic Acid
10%
Chelating Agents
9%
2-(3-(1-carboxy-5-(3-(4-iodobphenyl)ureido)pentyl)ureido)pentanedioic acid
9%
Primates
9%
Infections
9%
Animal Models
9%
Peptides
9%
Atherosclerosis
9%
Theoretical Models
9%
Dendritic Cells
8%
Chemical Compounds
Antigen
48%
Positron
17%
Collagen
16%
Photon Emission
13%
Dose
9%
Nanoparticle
8%
Bortezomib
8%
Pharmacokinetics
8%
Chelating Agent
7%
Radiopharmaceutical
6%
Fluorescence
6%
Antisense Oligonucleotide
6%
Radioisotope
6%
Urea
6%
Glycosphingolipid
6%
Granulation
6%
Sterol
5%
Clearance
5%
Implant
5%
Mammalian Cell
5%
Residence Time
5%
Epitope
5%
